Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kinuko Mitani

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
International Journal of Hematology|April 11, 2009
Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative studyYukio Kobayashi, Kensei Tobinai, Akihiro Takeshita, et al.
Blood Advances|August 4, 2025
Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemiaJong Wook Lee, Jun Ho Jang, Hirohito Yamazaki, et al.
Cancer Genomics & Proteomics|August 10, 2019
Gene Expression Profiles of CD133-positive Fractions Predict the Survival of Individuals with Acute Myeloid LeukemiaYoshihiro Yamashita, Jun Ohashi, Yuji Hirai, et al.
Cancer Biomarkers : Section a of Disease Markers|April 11, 2016
Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromesSumiko Kobayashi, Yasunori Ueda, Yasuhito Nannya, et al.
Therapeutic Advances in Hematology|February 24, 2025
Safety and efficacy of luspatercept in treating anemia associated with myelodysplastic syndrome with ring sideroblasts in Asian patients who require red blood cell transfusions: a phase II bridging studyChunkang Chang, Takahiro Suzuki, Yang Liang, et al.
International Journal of Hematology|July 31, 2019
Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromesHiroshi Kawabata, Kensuke Usuki, Maki Shindo-Ueda, et al.
International Journal of Hematology|May 13, 2017
Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registryHiroshi Kawabata, Kaoru Tohyama, Akira Matsuda, et al.
Haematologica|September 14, 2014
Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in JapanTomohiro Aoki, Koji Izutsu, Ritsuro Suzuki, et al.
Leukemia Research|June 20, 2018
Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: From the Japanese central review studyAkira Matsuda, Hiroshi Kawabata, Kaoru Tohyama, et al.
British Journal of Haematology|November 5, 2020
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label studyJun Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
International Journal of Hematology|April 11, 2009
Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative studyYukio Kobayashi, Kensei Tobinai, Akihiro Takeshita, et al.
Blood Advances|August 4, 2025
Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemiaJong Wook Lee, Jun Ho Jang, Hirohito Yamazaki, et al.
Cancer Genomics & Proteomics|August 10, 2019
Gene Expression Profiles of CD133-positive Fractions Predict the Survival of Individuals with Acute Myeloid LeukemiaYoshihiro Yamashita, Jun Ohashi, Yuji Hirai, et al.
Cancer Biomarkers : Section a of Disease Markers|April 11, 2016
Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromesSumiko Kobayashi, Yasunori Ueda, Yasuhito Nannya, et al.
Therapeutic Advances in Hematology|February 24, 2025
Safety and efficacy of luspatercept in treating anemia associated with myelodysplastic syndrome with ring sideroblasts in Asian patients who require red blood cell transfusions: a phase II bridging studyChunkang Chang, Takahiro Suzuki, Yang Liang, et al.
International Journal of Hematology|July 31, 2019
Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromesHiroshi Kawabata, Kensuke Usuki, Maki Shindo-Ueda, et al.
International Journal of Hematology|May 13, 2017
Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registryHiroshi Kawabata, Kaoru Tohyama, Akira Matsuda, et al.
Haematologica|September 14, 2014
Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in JapanTomohiro Aoki, Koji Izutsu, Ritsuro Suzuki, et al.
Leukemia Research|June 20, 2018
Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: From the Japanese central review studyAkira Matsuda, Hiroshi Kawabata, Kaoru Tohyama, et al.
British Journal of Haematology|November 5, 2020
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label studyJun Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, et al.
Pageof 15